Protein "on/off switch" controls breast cancer spread and immunotherapy response
Reviewed Despite their promise, immunotherapies fail to treat many cancers, including over 80% of some of the most advanced breast cancers. And many of those patients who do respond still experience metastases eventually. New research from Stanford University and the Arc Institute has revealed a better way to predict and improve patient responses. A team led by Lingyin Li, associate […]
Continue reading »